United States · Financial press · Investor's Business Daily

Regeneron, Sanofi Surge As Dupixent Wallops Sales Forecasts

Published by Investor's Business Daily · United States 1 h ago

Regeneron stock popped Thursday after its Sanofi-partnered allergic conditions drug, Dupixent, easily beat third-quarter calls. The post Regeneron, Sanofi Surge As Dupixent…

Read the full article on Investor's Business Daily Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.investors.com)

Also worth reading

The Wall Street Journal

Clues Point to Familiar Culprit in Massive Binance Crypto Heist: North Korea

Barron's

Regeneron, Sanofi Surge As Dupixent Wallops Sales Forecasts

Share

Also worth reading

Clues Point to Familiar Culprit in Massive Binance Crypto Heist: North Korea

Coinbase Stock, Strategy, and Circle Aren’t Binance. Crypto Investors Should Still Worry.